JY
NMRD

Jeff Yass’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Jeff Yass’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$90K – 14155
2021
Q3 		$90K Sell
15,000
-74,700
-83% -$538K ﹤0.01% 12121
2021
Q2 		$928K Buy
89,700
+63,800
+246% +$609K ﹤0.01% 7968
2021
Q1 		$198K Buy
+25,900
New +$171K ﹤0.01% 11433

Other funds holding NMRD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jeff Yass's NMRD Position: Q4 2023 in Review

Jeff Yass sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q4 2023, closing a stake of 20,230 shares — an estimated $6.53K sold.

Jeff Yass first reported a position in NMRD in Q1 2018 and held it in 9 quarters. The position peaked at $273K in Q1 2022. 21 funds tracked by Wall St. Rank hold NMRD as of Q4 2023.

  • Jeff Yass reported no remaining Nemaura Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jeff Yass sold 20,230 Nemaura Medical, Inc. Common Stock shares in Q4 2023, an estimated $6.53K.
  • Jeff Yass first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
  • Jeff Yass's Nemaura Medical, Inc. Common Stock position peaked at $273K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.